{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:23:44Z","timestamp":1793741024567,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074082"],"award-info":[{"award-number":["82074082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202102020555"],"award-info":[{"award-number":["202102020555"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["XK2019002"],"award-info":[{"award-number":["XK2019002"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["XKP2019007"],"award-info":[{"award-number":["XKP2019007"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2020B020214001"],"award-info":[{"award-number":["2020B020214001"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.intimp.2021.107915","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:50:57Z","timestamp":1624927857000},"page":"107915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["\u03b2-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats"],"prefix":"10.1016","volume":"98","author":[{"given":"Huijuan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziren","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2021.107915_b0005","doi-asserted-by":"crossref","unstructured":"Z. Younossi, P. Golabi, L. de Avila, J. Paik, M. Srishord, N. Fukui, Y. Qiu, L. Burns, A. Afendy, F.J.J.o.h. Nader, The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis, 71(4) (2019) 793\u2013801. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021.","DOI":"10.1016\/j.jhep.2019.06.021"},{"key":"10.1016\/j.intimp.2021.107915_b0010","doi-asserted-by":"crossref","unstructured":"K. Gariani, F.J.E.c. Jornayvaz, Pathophysiology of NASH in endocrine diseases, (2021). https:\/\/doi.org\/10.1530\/ec-20-0490.","DOI":"10.1530\/EC-20-0490"},{"key":"10.1016\/j.intimp.2021.107915_b0015","doi-asserted-by":"crossref","unstructured":"M. Gill, A.J.W.j.o.h. Majumdar, Metabolic associated fatty liver disease: addressing a new era in liver transplantation, 12(12) (2020) 1168\u20131181. https:\/\/doi.org\/10.4254\/wjh.v12.i12.1168.","DOI":"10.4254\/wjh.v12.i12.1168"},{"issue":"6","key":"10.1016\/j.intimp.2021.107915_b0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2021.107915_b0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fcell.2020.00139","article-title":"Involvement of nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 inflammasome in the pathogenesis of liver diseases","volume":"8","author":"Shi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.intimp.2021.107915_b0030","doi-asserted-by":"crossref","unstructured":"J.C. Ralston, C.L. Lyons, E.B. Kennedy, A.M. Kirwan, H.M. Roche, Fatty acids and NLRP3 inflammasome-mediated inflammation in metabolic tissues, in: P.J. Stover, R. Balling (Eds.), Annual Review of Nutrition, Vol 372017, pp. 77\u2013102.","DOI":"10.1146\/annurev-nutr-071816-064836"},{"issue":"6","key":"10.1016\/j.intimp.2021.107915_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2021.107915_b0040","doi-asserted-by":"crossref","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.intimp.2021.107915_b0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","article-title":"Hypoxia, oxidative stress and inflammation","volume":"125","author":"McGarry","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2021.107915_b0050","doi-asserted-by":"crossref","unstructured":"B. Mwaikambo, C. Yang, S. Chemtob, P.J.T.J.o.b.c. Hardy, Hypoxia up-regulates CD36 expression and function via hypoxia-inducible factor-1- and phosphatidylinositol 3-kinase-dependent mechanisms, 284(39) (2009) 26695\u201326707. https:\/\/doi.org\/10.1074\/jbc.M109.033480.","DOI":"10.1074\/jbc.M109.033480"},{"issue":"10","key":"10.1016\/j.intimp.2021.107915_b0055","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1111\/liv.14519","article-title":"Hypoxia-inducible factor 2alpha drives hepatosteatosis through the fatty acid translocase CD36","volume":"40","author":"Rey","year":"2020","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.intimp.2021.107915_b0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2021.107915_b0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2337\/db14-0582","article-title":"Regulation of AMPK activaticin by CD36 links fatty acid uptake to beta-oxidation","volume":"64","author":"Samovski","year":"2015","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.intimp.2021.107915_b0070","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.celrep.2017.03.011","article-title":"Liver-specific activation of AMPK prevents steatosis on a high-fructose diet","volume":"18","author":"Woods","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.107915_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010015","article-title":"Nonalcoholic fatty liver disease: a challenge from mechanisms to therapy","volume":"9","author":"Tarantino","year":"2019","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.intimp.2021.107915_b0080","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1039\/c3fo60295h","article-title":"Origin and concept of medicine food homology and its application in modern functional foods","volume":"4","author":"Hou","year":"2013","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2021.107915_b0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.phymed.2017.12.024","article-title":"Protective role of beta-patchoulene from Pogostemon cablin against indomethacin-induced gastric ulcer in rats: Involvement of anti-inflammation and angiogenesis","volume":"39","author":"Wu","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2021.107915_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114260","article-title":"beta-patchoulene simultaneously ameliorated dextran sulfate sodium-induced colitis and secondary liver injury in mice via suppressing colonic leakage and flora imbalance","volume":"182","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107915_b0095","doi-asserted-by":"crossref","unstructured":"N. Xu, H. Luo, M. Li, J. Wu, X. Wu, L. Chen, Y. Gan, F. Guan, M. Li, Z. Su, J. Chen, Y.J.B. Liu, p. Biomedecine, pharmacotherapie, \u03b2-patchoulene improves lipid metabolism to alleviate non-alcoholic fatty liver disease via activating AMPK signaling pathway, Biomedecine pharmacotherapie 134 (2020) 111104. https:\/\/doi.org\/10.1016\/j.biopha.2020.111104.","DOI":"10.1016\/j.biopha.2020.111104"},{"issue":"42","key":"10.1016\/j.intimp.2021.107915_b0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/0973-1296.153084","article-title":"Effects of Pogostemon cablin Blanco extract on hypoxia induced rabbit cardiomyocyte injury","volume":"11","author":"Lim","year":"2015","journal-title":"Pharmacognosy Magazine"},{"key":"10.1016\/j.intimp.2021.107915_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2016.04.028","article-title":"Anti-inflammatory activity of beta-patchoulene isolated from patchouli oil in mice","volume":"781","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.107915_b0110","doi-asserted-by":"crossref","unstructured":"W. Liang, A.L. Menke, A. Driessen, G.H. Koek, J.H. Lindeman, R. Stoop, L.M. Havekes, R. Kleemann, A.M. van den Hoek, Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology, Plos One 9(12) (2014). https:\/\/doi.org\/10.1371\/journal.pone.0115922.","DOI":"10.1371\/journal.pone.0115922"},{"issue":"2","key":"10.1016\/j.intimp.2021.107915_b0115","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1530\/EC-20-0490","article-title":"Pathophysiology of NASH in endocrine diseases","volume":"10","author":"Gariani","year":"2021","journal-title":"Endocr. Connect."},{"issue":"2","key":"10.1016\/j.intimp.2021.107915_b0120","article-title":"Oxidative stress and antioxidant biomarkers in clinical and experimental models of non-alcoholic fatty liver disease","volume":"55","author":"Ore","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.intimp.2021.107915_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106730","article-title":"Potential anti-inflammatory effect of dapagliflozin in HCHF diet-induced fatty liver degeneration through inhibition of TNF-alpha, IL-1 beta, and IL-18 in rat liver","volume":"86","author":"ElMahdy","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"13","key":"10.1016\/j.intimp.2021.107915_b0130","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/ars.2014.5994","article-title":"Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?","volume":"22","author":"Abais","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2021.107915_b0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopha.2018.08.067","article-title":"TXNIP mediated the oxidative stress response in glomerular mesangial cells partially through AMPK pathway","volume":"107","author":"Xu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.intimp.2021.107915_b0140","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"issue":"7384","key":"10.1016\/j.intimp.2021.107915_b0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.intimp.2021.107915_b0150","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/hepr.12883","article-title":"Hepatic nucleotide binding oligomerization domain-like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease","volume":"47","author":"Mitsuyoshi","year":"2017","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.intimp.2021.107915_b0155","article-title":"Silencing HIF-1alpha aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-alpha\/ANGPTL4 singling pathway","author":"He","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2021.107915_b0160","doi-asserted-by":"crossref","unstructured":"M. Eugenia Miquilena-Colina, E. Lima-Cabello, S. Sanchez-Campos, M. Victoria Garcia-Mediavilla, M. Fernandez-Bermejo, T. Lozano-Rodriguez, J. Vargas-Castrillon, X. Buque, B. Ochoa, P. Aspichueta, J. Gonzalez-Gallego, C. Garcia-Monzon, Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C, Gut 60(10) (2011) 1394\u20131402. https:\/\/doi.org\/10.1136\/gut.2010.222844.","DOI":"10.1136\/gut.2010.222844"},{"key":"10.1016\/j.intimp.2021.107915_b0165","doi-asserted-by":"crossref","unstructured":"D. Greco, A. Kotronen, J. Westerbacka, O. Puig, P. Arkkila, T. Kiviluoto, S. Laitinen, M. Kolak, R.M. Fisher, A. Hamsten, P. Auvinen, H. Yki-Jarvinen, Gene expression in human NAFLD, Am. J. Physiol. Gastrointestinal Liver Physiol. 294(5) (2008) G1281\u2013G1287. https:\/\/doi.org\/10.1152\/ajpgi.00074.2008.","DOI":"10.1152\/ajpgi.00074.2008"},{"issue":"8","key":"10.1016\/j.intimp.2021.107915_b0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","article-title":"AMPK as a therapeutic target for treating metabolic diseases","volume":"28","author":"Day","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2021.107915_b0175","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2021.107915_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107173","article-title":"Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses","volume":"91","author":"Gong","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2021.107915_b0185","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis","volume":"86","author":"Eberle","year":"2004","journal-title":"Biochimie"},{"key":"10.1016\/j.intimp.2021.107915_b0190","doi-asserted-by":"crossref","unstructured":"A. Montagner, A. Polizzi, E. Fouche, S. Ducheix, Y. Lippi, F. Lasserre, V. Barquissau, M. Regnier, C. Lukowicz, F. Benhamed, A. Iroz, J. Bertrand-Michel, T. Al Saati, P. Cano, L. Mselli-Lakhal, G. Mithieux, F. Rajas, S. Lagarrigue, T. Pineau, N. Loiseau, C. Postic, D. Langin, W. Wahli, H. Guillou, Liver PPAR alpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD, Gut 65(7) (2016) 1202\u20131214. https:\/\/doi.org\/10.1136\/gutjnl-2015-310798.","DOI":"10.1136\/gutjnl-2015-310798"},{"issue":"3","key":"10.1016\/j.intimp.2021.107915_b0195","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR alpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107915_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010360","article-title":"Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL\/6 mice model via AMPK\/Sirt1\/SREBP-1c\/PPAR gamma pathway","volume":"21","author":"Chyau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2021.107915_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041005","article-title":"Noninvasive diagnosis of NAFLD and NASH","volume":"9","author":"Piazzolla","year":"2020","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.intimp.2021.107915_b0210","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/CIRCULATIONAHA.106.626135","article-title":"Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma - A novel marker of insulin resistance","volume":"114","author":"Handberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2021.107915_b0215","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/920676","article-title":"Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes","volume":"2014","author":"Tarantino","year":"2014","journal-title":"Oxid. Med. Cell Longev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921005518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:41:59Z","timestamp":1762551719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921005518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":43,"alternative-id":["S1567576921005518"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107915","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107915"}}